Scott J. Garza

机构：Pfizer (United States), Université Bourgogne Franche-Comté

发表论文 50 篇 · 总被引 296 次 · h-index 5

代表论文

• An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735 (2012 · Molecular Cancer Therapeutics · 被引 97)
• CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety (2025 · Cancer Cell · 被引 72)
• Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2 (2015 · The EMBO Journal · 被引 65)
• Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871) (2013 · Molecular Cancer Therapeutics · 被引 37)
• Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model (1999 · Cancer · 被引 13)
• Abstract 595: Preclinical development of the CDK4 selective inhibitor PF-07220060: Increased CDK4 versus CDK6 inhibition leads to improved anti-tumor efficacy at therapeutic concentrations (2024 · Cancer Research · 被引 3)